It gave us one hint that frequency of EGFR mutation might be notably underestimated, and it also might be the potential explanation of some rapid progressed lower-grade glioma (histopathological diagnosis) which might essentially be higher-grade glioma in molecular level. Here, EGFR is linked to central nervous system cancer.